Chemed (STU:CXM) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CXM Chemed Corp STU:CXM
69 GF Score
Price €462.00
GF Value €589.57
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Chemed Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:CXM vs PACS, LFST, UHS: Short Interest Comparison

For the Medical Care Facilities subindustry, Chemed's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chemed Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Short Interest distribution charts can be found below:

* The bar in red indicates where Chemed's Short Interest falls into.


STU:CXM
69GF Score
Chemed Corp STU:CXM
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chemed (STU:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €462.00 is trading 21.6% below its estimated GF Value™ of €589.57. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for STU:CXM:

  • Short Interest:
  • GF Value™: €589.57 vs. price of €462.00 (21.6% below fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the STU:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Other Exchanges CHE:USACXM:Germany
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
69GF Score

Get the complete analysis for STU:CXM

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€462.00
Price
€589.57
GF Value